Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells
Immunity · 2026
DOI: 10.1016/j.immuni.2025.12.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2026. Verfasst von Nicholas M Adams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Chromatin, Interferon Type I. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Damon Runyon Cancer Research Foundation, National Institutes of Health.
Abstract (Originalsprache)
Type I interferons (IFN-I), including IFN-β and multiple IFN-α subtypes, are key antiviral proteins encoded within a single large locus. Here, we studied how the chromatin organization of this locus controls cell-type-specific IFN-I responses. The professional IFN-I-producing plasmacytoid dendritic cells (pDCs) simultaneously induced nearly all IFN-I subtypes across the locus. During pDC differentiation, the IFN-I locus translocated into the active intranuclear chromosomal compartment. It also underwent cohesin-dependent reorganization of its three-dimensional chromatin structure; accordingly, IFN-I production by pDCs was cohesin dependent. The promoters of most IFN-I genes harbored open chromatin peaks specifically in pDCs. The preemptive intranuclear translocation and promoter opening of IFN-I genes in pDCs were mediated by the pDC-enriched transcription factor interferon regulatory factor (IRF)8. Several IRF8- and/or cohesin-binding regulatory regions within the IFN-I locus facilitated IFN-I gene induction in pDCs, as confirmed by single-cell multiome analysis. Thus, the unique IFN-I-producing capacity of pDCs is facilitated by anticipatory chromatin organization imparted by IRF8 and cohesin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA; Applied Bioinformatics Laboratories, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Applied Bioinformatics Laboratories, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Biozentrum, Ludwig Maximilians University Munich, 82152, Planegg-Martinsried, Germany.
- Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Förderung
- NIAID NIH HHS
- Damon Runyon Cancer Research Foundation
- National Institutes of Health
- German Research Foundation
Zitieren
APA
Adams, N. M., Galitsyna, A., Tiniakou, I., Esteva, E., Ra, A. C., Ullrich, S., Yeung, S. T., Tan, Y., Pucella, J. N., Dolgalev, I., Levy, D. E., Khanna, K. M., Solovei, I., Mirny, L. A., & Reizis, B. (2026). Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells. Immunity. https://doi.org/10.1016/j.immuni.2025.12.005
Vancouver
Adams NM, Galitsyna A, Tiniakou I, Esteva E, Ra AC, Ullrich S, et al. Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells. Immunity. 2026. doi:10.1016/j.immuni.2025.12.005
BibTeX
@article{Adams2026,
author = {Adams, Nicholas M and Galitsyna, Aleksandra and Tiniakou, Ioanna and Esteva, Eduardo and Ra, Ai C and Ullrich, Simon and Yeung, Stephen T and Tan, Yanjun and Pucella, Joseph N and Dolgalev, Igor and Levy, David E and Khanna, Kamal M and Solovei, Irina and Mirny, Leonid A and Reizis, Boris},
title = {Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells},
journal = {Immunity},
year = {2026},
doi = {10.1016/j.immuni.2025.12.005}
}
EUVIMED